BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28696562)

  • 1. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.
    Zou Y; Li X; Wang C; Wang J; Wang F; Ma L; You W; Li C
    Intern Med J; 2017 Oct; 47(10):1147-1153. PubMed ID: 28696562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
    Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
    J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
    Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
    Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
    Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
    Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation.
    Zhu W; Deng CJ; Xuan LP; Dai HJ; Zhao ZY; Wang TG; Li M; Lu JL; Xu Y; Chen YH; Wang WQ; Bi YF; Xu M
    Biomed Environ Sci; 2020 Apr; 33(4):217-226. PubMed ID: 32438959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
    Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalent peripheral arterial disease and inflammatory burden.
    Cauley JA; Kassem AM; Lane NE; Thorson S;
    BMC Geriatr; 2016 Dec; 16(1):213. PubMed ID: 27938334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.
    Ni L; Yu D; Wu T; Jin F
    Medicine (Baltimore); 2021 Feb; 100(6):e24743. PubMed ID: 33578624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.
    Britton KA; Mukamal KJ; Ix JH; Siscovick DS; Newman AB; de Boer IH; Thacker EL; Biggs ML; Gaziano JM; Djoussé L
    Vasc Med; 2012 Apr; 17(2):85-93. PubMed ID: 22402937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
    Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population.
    Sun W; Zhang D; Sun J; Xu B; Sun K; Wang T; Ren C; Li J; Chen Y; Xu M; Bi Y; Xu Q; Wang W; Gu Y; Ning G
    QJM; 2015 Aug; 108(8):617-24. PubMed ID: 25614616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    Gummesson A; Strömberg U; Schmidt C; Kullberg J; Angerås O; Lindgren S; Hjelmgren O; Torén K; Rosengren A; Fagerberg B; Brandberg J; Bergström G
    PLoS One; 2018; 13(8):e0202666. PubMed ID: 30133541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankle systolic pressure index in non-diabetic non-alcoholic fatty liver disease: A case-control study.
    Taharboucht S; Guermaz R; Brouri M; Bengherbia L; Chibane A
    J Med Vasc; 2023; 48(5-6):154-162. PubMed ID: 38035921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.